About our research:

Oslo Myeloma Center is the largest center for clinical myeloma research in the Nordics.

Since 2015, 982 patients have been enrolled in 64 clinical studies in patients with smoldering multiple myeloma and multiple myeloma including newly diagnosed and relapsed/refractory patients in phase 1, 2, 3 and 4 studies.

Year Patient Number
2015 37
2016 67
2017 83
2018 98
2019 120
2020 83
2021 82
2022 105
2023 147
2024 110
August 2025 50

Number of patients included in the different phases by August 2025:

Phase 1 - 122 patients
Phase 2 - 333 patients
Phase 3 - 454 patients
Phase 4: 73 Patients

We maintain a comprehensive myeloma registry that includes both prospective and retrospective data. Additionally, our biobank collects materials that support translational research nationally.

 
Scroll to top